Weight Loss Medication Side Effects: What to Expect

by Burst Health

Side effects are part of every prescription medication. They are one of the things a practitioner is required to discuss with a patient before prescribing, and one of the things the broader Australian regulatory system is built to monitor over time. Understanding how this system works, and what part the patient plays in it, is more useful than trying to compile a generic list of side effects from a webpage.

This article is general information only. It does not list the specific side effects of any individual medication. The Consumer Medicine Information leaflet that comes with a particular medication, and the prescribing practitioner, are the authoritative sources of information for any medication a patient is taking. Side effect profiles vary between medications and between individuals.

Why Every Prescription Medication Has a Side Effect Profile

A medication that has been entered on the Australian Register of Therapeutic Goods has passed through a regulatory review that examines both its potential benefits and its potential harms. No medication is approved on the basis that it produces no side effects. Approval reflects a judgement that, in the population it has been studied in and for the indication it is approved for, the benefits outweigh the risks for appropriate patients under appropriate clinical oversight.

This is true of weight loss medications and it is true of every other prescription medicine. A practitioner's role is to apply that general regulatory position to the specific patient in front of them by:

  • weighing the relevant benefits and risks for that individual

  • considering the patient's other medications, conditions, and circumstances

  • explaining the relevant side effects so the patient can give informed consent

  • agreeing a plan for monitoring and follow-up

  • adjusting the plan if side effects affect the patient over time

The Consumer Medicine Information leaflet, which is required for every prescription medicine in Australia and is available through the TGA website, lists known side effects in plain-English form. The Product Information document, also available through the TGA, is the more detailed clinical document used by prescribers and pharmacists. Both documents are updated as new safety information emerges.

Categories Practitioners Discuss During the Conversation

When a practitioner explains side effects, the conversation usually covers a few different categories:

  • Common side effects. Effects that occur in a meaningful proportion of patients. These tend to be discussed in detail because the patient is statistically likely to encounter at least some of them.

  • Less common side effects. Effects that occur in a smaller proportion of patients. A practitioner will usually mention these so the patient can recognise them if they occur.

  • Serious or rare side effects. Effects that occur infrequently but can be significant when they do. A practitioner will explain the warning signs and what to do if they appear.

  • Drug interactions. Effects that arise because of the way one medication interacts with another. This is one reason a complete list of current medications matters so much in the consultation.

The specific list within each category is medication-specific, and is set out in the Consumer Medicine Information leaflet that accompanies each prescription.

Why Side Effects Vary Between Individuals

Two patients on the same medication can have very different experiences. Several factors contribute to that variability:

  • baseline health and the presence of other medical conditions

  • other medications and how they interact

  • age, weight, sex, and other physical factors

  • genetic differences in how the body processes medication

  • diet, alcohol, smoking, and other lifestyle factors

  • the dose, the timing, and how the medication is taken

  • adherence and consistency

This variability is one reason ongoing review matters. A side effect that is mild for one patient may be more significant for another, and a practitioner will adjust the plan based on the patient in front of them.

Informed Consent and the Practitioner Conversation

In Australia, prescribers are expected to provide patients with enough information about benefits, risks, alternatives, and reasonable expectations to allow the patient to give informed consent. For weight loss medications, this typically means a discussion of:

  • what the medication is intended to do

  • the side effects the patient should be aware of

  • what monitoring will be put in place

  • what the patient should do if they experience problems

  • the alternatives, including non-medication options and the option of not treating at this time

  • what realistic ongoing review will look like

A good consultation leaves the patient with a clear sense of what to expect, what to watch for, and how to get back in contact if something changes. The Medical Board of Australia, through the Australian Health Practitioner Regulation Agency, holds all registered prescribers to a Code of Conduct that includes obligations around informed consent and communication of risk.

Dose Titration and Tolerability

Many medications used in clinical care are introduced gradually. A practitioner may start at a low dose and increase over time, depending on how the patient is responding and what side effects appear. This is a general principle of clinical practice. The exact approach depends on the medication and the patient.

Dose titration serves a few purposes:

  • it allows the body to adjust, which can reduce some side effects

  • it gives the practitioner a chance to detect issues early

  • it lets the plan be tailored to the individual rather than applied uniformly

  • it provides natural review points where the plan can be adjusted

Patients should follow the prescriber's instructions about doses and changes, and should not adjust doses on their own.

When to Contact Your Practitioner

Practitioners typically give patients clear guidance on when to get in touch. As a general principle, patients should contact the prescriber or seek medical advice when they experience:

  • side effects that are persistent, worsening, or interfering with daily life

  • any reaction that feels unusual or unexpected

  • symptoms suggestive of a serious adverse event, including but not limited to severe allergic reactions, chest pain, breathing difficulties, severe abdominal pain, or signs of an electrolyte disturbance

  • new symptoms that appear after starting or changing a medication

  • symptoms that affect mood, mental health, or behaviour

In an emergency, Australian patients should call 000 or go to a hospital emergency department. For urgent but non-emergency advice, healthdirect Australia provides a 24-hour helpline on 1800 022 222. For routine concerns, the prescriber, the patient's general practitioner, or the dispensing pharmacist are appropriate points of contact.

The Three-Party Safety Model

Australia's medication safety system is built around three parties who each have a role to play in the patient's safety:

  • The prescribing practitioner, who assesses the patient, prescribes, reviews ongoing care, and adjusts the plan over time.

  • The dispensing pharmacist, who independently checks the prescription before dispensing, reviews the medication history, provides counselling at supply, and can answer questions between appointments.

  • The patient, who follows the prescribed plan, attends reviews, reports symptoms and changes, and provides feedback that allows the plan to be adjusted.

Each party can identify safety concerns the others might not see. The patient is uniquely positioned to notice early symptoms, changes in mood, and effects on daily life. The pharmacist sees the complete dispensing history and any interactions across all medications. The prescriber holds the broader clinical picture. Communication between the three is one of the things that makes the system work.

The Pharmacist's Role in Side Effect Counselling

The dispensing pharmacist is an independent clinician in the patient's care. Before a prescription is dispensed, the pharmacist:

  • reviews the prescription for safety, including dose and interactions

  • checks the patient's medication history where available

  • can provide counselling at the point of supply, including discussing the most common side effects

  • can answer questions between practitioner appointments

The pharmacist is not the prescriber, and cannot change the prescription. However, the pharmacist plays an important safety role, and patients are encouraged to use that resource.

How the Australian Pharmacovigilance System Works

Australia has a well-developed pharmacovigilance system, which is the formal name for the system that monitors the safety of medicines after they are in use. The system has several layers:

  • Sponsor obligations. Companies that supply medicines in Australia are required by law to monitor the safety of their medicines, submit periodic safety reports to the TGA, and report serious adverse events promptly.

  • Healthcare professional reporting. Prescribers and pharmacists can report adverse events to the TGA through dedicated reporting pathways.

  • Consumer reporting. Patients can report side effects directly to the TGA, through their prescriber, through their pharmacist, or through NPS MedicineWise.

  • The Database of Adverse Event Notifications (DAEN). The TGA's public database, where adverse event reports are published in de-identified form.

  • The Black Triangle Scheme. A scheme by which new prescription medicines, or medicines being used in new ways, are flagged with a black triangle symbol on Consumer Medicine Information and Product Information documents. The symbol indicates that the medicine is under additional monitoring and that reporting any adverse event is particularly valuable.

  • Periodic safety review. Ongoing review of safety data, both nationally and internationally, which can lead to updated Consumer Medicine Information leaflets, prescribing guidance, and clinician communications.

This system is not abstract. The information it produces feeds back into the Consumer Medicine Information leaflet, the Product Information document, and the everyday advice prescribers and pharmacists give to patients.

Reporting Side Effects to the TGA

Patients can report side effects in several ways:

  • through the TGA website at tga.gov.au, using its online reporting form

  • through their prescriber, who can submit a report on the patient's behalf

  • through the dispensing pharmacist, who can submit a report

  • through NPS MedicineWise, which runs Medicines Line, a service that allows the public to ask questions and report concerns

Reports do not need to prove a connection between the medication and the side effect. The role of the reporter is to describe what happened. The role of the TGA is to investigate, look for patterns across the population, and act on what it finds. A single report can contribute to a broader signal that leads to updated information for clinicians and patients.

Frequently Asked Questions

What side effects should I expect from weight loss medication?

The answer is medication-specific. The Consumer Medicine Information leaflet that comes with the medication, available through tga.gov.au, lists the known side effects in plain English. The prescribing practitioner is the right person to explain which ones are most relevant for an individual patient.

How long do side effects usually last?

This depends on the medication, the dose, the individual, and the side effect itself. Some early side effects settle as the body adjusts. Others may persist or appear later. A practitioner will discuss what to expect and review progress over time.

What should I do if a side effect is bothering me?

Contact the prescriber, the patient's general practitioner, or the dispensing pharmacist. If symptoms feel serious or unusual, seek urgent advice. Do not adjust or stop a prescribed medication without speaking to a practitioner.

Where can I report a side effect?

To the TGA through tga.gov.au, or via the prescriber, the dispensing pharmacist, or NPS MedicineWise. Reports help improve the information available to clinicians and patients across Australia.

What does the black triangle on a medication mean?

The black triangle symbol indicates that the medicine is under additional monitoring by the TGA. It is not a warning that something is wrong. It signals that the TGA is collecting additional information and that reporting any adverse event is particularly valuable for those medicines.

Are side effects a sign the medication is working?

This is a common assumption, and it is not reliable. Side effects and clinical effects are separate things. A practitioner is the right person to discuss what is happening clinically for an individual patient.

Further Information

For authoritative Australian information on side effects, monitoring, and adverse event reporting, useful sources include:

  • The Therapeutic Goods Administration (tga.gov.au), including the Database of Adverse Event Notifications and the Black Triangle Scheme

  • The Consumer Medicine Information leaflet for the specific medication, available through tga.gov.au

  • NPS MedicineWise (nps.org.au), including the Medicines Line consumer service

  • Healthdirect Australia (healthdirect.gov.au)

  • The Australian Health Practitioner Regulation Agency (ahpra.gov.au)

This article is general information only and does not replace individualised medical advice. Patients should speak with a registered Australian healthcare practitioner about any specific medication they are taking or considering.

Back to Healthcare blog